FDA Orders St. Jude to Conduct Three-Year Review on Riata, Durata and Other Leads

The FDA ordered St. Jude Medical to launch a three-year postmarket review on its recalled Riata and Riata ST defibrillator leads as well as for its QuickFlex LV CRT, QuickSite LV CRT, Riata ST Optim and Durata leads.
Mass Device